How Ozempic and RFK Jr will impact US fmcg prospects

ozempic aom obesity medicine health diabetes GettyImages-1393991963

How much of a threat UPF concerns pose to the structural growth prospects of the packaged food industry is being actively debated, says Warren Ackerman, head of European consumer staples research at Barclays

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW